{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T17:07:54Z","timestamp":1763831274991,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01AI116723-06"],"award-info":[{"award-number":["2R01AI116723-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030 175585"],"award-info":[{"award-number":["320030 175585"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bmcl.2022.128546","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T21:39:55Z","timestamp":1641937195000},"page":"128546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antischistosomal tetrahydro-\u03b3-carboline sulfonamides"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1738-1212","authenticated-orcid":false,"given":"Rongguo","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-543X","authenticated-orcid":false,"given":"Derek A.","family":"Leas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"H\u00e4berli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Cal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-2336","authenticated-orcid":false,"given":"Jonathan L.","family":"Vennerstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128546_b0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"Gryseels","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmcl.2022.128546_b0010","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2022.128546_b0015","doi-asserted-by":"crossref","first-page":"e02582","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2022.128546_b0020","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.actatropica.2010.08.020","article-title":"From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis","volume":"120","author":"Utzinger","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmcl.2022.128546_b0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"Olliaro","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2022.128546_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.bmcl.2022.128546_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni","volume":"3","author":"Melman","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2022.128546_b0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4269\/ajtmh.2011.10-0542","article-title":"Human schistosomiasis resistance to praziquantel in China: should we be worried?","volume":"85","author":"Seto","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmcl.2022.128546_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2011.03.004","article-title":"Pharmacology and potential physiological significance of schistosome multidrug resistance transporters","volume":"132","author":"Kasinathan","year":"2012","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmcl.2022.128546_b0050","series-title":"Neglected tropical diseases: drug discovery and development","first-page":"187","article-title":"Drug discovery and development for schistosomiasis","author":"Caffrey","year":"2019"},{"key":"10.1016\/j.bmcl.2022.128546_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/138527207779316426","article-title":"The Witkop-Winterfeldt oxidation of indoles","volume":"11","author":"Mentel","year":"2007","journal-title":"Curr Org Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0060","unstructured":"Ivashchenko AA, Ivashchenko AV, Tkachenko SY, Okun IM, Savchuk NF. Preparation of derivatives of pyrrolo[4,3-b]indoles, \u03b3 -carbolines and azepino[4,3-b]indoles as ligands of 5-HT6.receptors for treating CNS diseases and pharmaceutical compositions containing them. PCT Int. Appl. (2008), WO 2008060190 A2 20080522."},{"key":"10.1016\/j.bmcl.2022.128546_b0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tet.2010.11.110","article-title":"The Witkop-Winterfeldt oxidation converts tetrahydropyridoindoles into pyrroloquinolones and cinnolines by an unprecedented scaffold rearrangement","volume":"67","author":"Mentel","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2022.128546_b0070","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/molecules17021177","article-title":"Mild and efficient Winterfeldt oxidation of 1,2,3,4-tetrahydro-\u03b3-carbolines for the synthesis of dihydropyrrolo[3,2-b]-quinolones and pyrrolo[3,2-b]quinolones","volume":"17","author":"Sheng","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128546_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/jm00307a023","article-title":"Hexahydroazepino[4,5-b]indoles","volume":"11","author":"Hester","year":"1968","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0080","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/0040-4039(95)00530-P","article-title":"Practical syntheses of hexahydroazepino[4,5-b]- and hexahydroazocino[4,5-b]indoles","volume":"36","author":"Diker","year":"1995","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2022.128546_b0085","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1021\/acs.jmedchem.0c01050","article-title":"Identification, Structure-activity relationship, and biological characterization of 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles as a novel class of CFTR potentiators","volume":"63","author":"Brindani","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0090","first-page":"20","article-title":"Pyridoindole compounds as modulators of NMDA receptor and acetylcholinesterase and their preparation and use in the treatment of diseases","author":"Gant","year":"2010","journal-title":"PCT Int Appl"},{"key":"10.1016\/j.bmcl.2022.128546_b0095","first-page":"548","article-title":"Synthesis of novel \u03b3 -carboline derivatives and their in silico studies on 5HT1, H1 and CCR2 antagonist receptors","volume":"6","author":"Siddalingamurthy","year":"2014","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"10.1016\/j.bmcl.2022.128546_b0100","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.tetlet.2013.07.157","article-title":"Mild, efficient Fischer indole synthesis using 2,4,6-trichloro-1,3,5-triazine (TCT)","volume":"54","author":"Siddalingamurthy","year":"2013","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2022.128546_b0105","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1021\/acs.orglett.8b02377","article-title":"Biomimetic oxidative coupling cyclization enabling rapid construction of isochromanoindolenines","volume":"20","author":"Ye","year":"2018","journal-title":"Org Lett"},{"key":"10.1016\/j.bmcl.2022.128546_b0110","first-page":"38","article-title":"Synthesis of 2,3,4,5-tetrahydro-1H- \u03b3 -carbolinecarboxylic acids and their derivatives","volume":"52","author":"Ivashchenko","year":"2009","journal-title":"Izvestiya Vysshikh Uchebnykh Zavedenii Khimiya Khimicheskaya Tekhnologiya"},{"key":"10.1016\/j.bmcl.2022.128546_b0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmcl.2022.128546_b0120","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jm0100990","article-title":"A tool for lipophilicity determination in drug discovery. 2. basic and neutral compounds","volume":"44","author":"Lombardo","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0125","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/ac9912247","article-title":"A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates","volume":"72","author":"Bevan","year":"2000","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3075-5","article-title":"An in vitro toolbox to accelerate anti-malarial drug discovery and development","volume":"19","author":"Charman","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.bmcl.2022.128546_b0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41596-018-0101-y","article-title":"Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni","volume":"14","author":"Lombardo","year":"2019","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmcl.2022.128546_b0140","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1021\/jm900805v","article-title":"Synthesis and antiprotozoal activity of pyridyl analogues of pentamidine","volume":"52","author":"Bakunova","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128546_b0145","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/jac\/dkr178","article-title":"Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro","volume":"66","author":"Keiser","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:43:30Z","timestamp":1760773410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":29,"alternative-id":["S0960894X22000221"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128546","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antischistosomal tetrahydro-\u03b3-carboline sulfonamides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128546"}}